The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever
Open Access
- 3 April 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (4), 1149-1155
- https://doi.org/10.1002/art.10944
Abstract
Objective The clinical profile in familial Mediterranean fever (FMF), including its major manifestation, amyloidosis, is influenced by MEFV allelic heterogeneity and other genetic and/or environmental factors. In this study, we analyzed the contribution of genotypes at the MEFV and SAA1 loci to disease severity and to the development of amyloidosis, and further defined the factors affecting the clinical profile of FMF. Methods We investigated a sample of 277 FMF patients (154 men and 123 women), including 62 patients with nephropathic amyloidosis, in whom both FMF alleles had been identified. A detailed chart review, interview, and physical examination were undertaken to determine the patients' demographic characteristics, medical history, clinical manifestations, and treatment. The disease severity score was calculated from the Tel‐Hashomer key. Genotypes at the SAA1 locus (isoforms α, β, and γ) were determined in all patients. The SAA1 13C/T polymorphism of the SAA1 promotor was analyzed in a subset of cases. Results The male:female ratio (154:123, or 1.3) was higher among patients with amyloidosis (40:22, or 1.8) compared with patients without amyloidosis (114:101, or 1.1). Logistic regression analysis showed that homozygosity for the M694V allele (odds ratio [OR] 4.27, 95% confidence interval [95% CI] 2.01–9.07), the presence of the SAAα/α genotype (OR 2.99, 95% CI 1.47–6.09), the occurrence of arthritis attacks (OR 2.43, 95% CI 1.17–5.06), and male sex (OR 1.73, 95% CI 0.90–3.33) were significantly and independently associated with renal amyloidosis. Disease severity was mainly influenced by MEFV mutations and was not associated with genotypes at the SAA1 locus. The SAA1 13T allele was rare, being associated mainly with the SAA γ isoform, and not related to renal amyloidosis. Conclusion Overall, disease severity and the development of amyloidosis in FMF are differentially affected by genetic variations within and outside the MEFV gene.Keywords
This publication has 26 references indexed in Scilit:
- The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean feverEuropean Journal of Human Genetics, 2002
- Familial Mediterranean fever: prevalence, penetrance and genetic driftEuropean Journal of Human Genetics, 2001
- Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groupsEuropean Journal of Human Genetics, 2000
- MEFV-Gene Analysis in Armenian Patients with Familial Mediterranean Fever: Diagnostic Value and Unfavorable Renal Prognosis of the M694V Homozygous Genotype—Genetic and Therapeutic ImplicationsAmerican Journal of Human Genetics, 1999
- Phenotype–genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosisEuropean Journal of Human Genetics, 1999
- Familial Mediterranean Fever — Amyloidosis and the Val726Ala MutationThe New England Journal of Medicine, 1998
- Criteria for the diagnosis of familial mediterranean feverArthritis & Rheumatism, 1997
- A novel allelic variant of serum amyloic A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA– amyloidosisHuman Molecular Genetics, 1995
- Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Colchicine in the Prevention and Treatment of the Amyloidosis of Familial Mediterranean FeverThe New England Journal of Medicine, 1986